Liver Cancer Therapeutics Market by Therapy Type (Chemotherapy, Immunotherapy, and Targeted Therapy), by Distribution Channel (Retail Pharmacy, Online Pharmacy, and Hospital Pharmacy) - Global Outlook & Forecast 2022-2030

  • Report Code : gpr833746
  • Pages : 183
  • Published On : Sep 2022
  • Industry : Healthcare and Pharmaceuticals
  • Format :

Choose License Type

Single User License: US$ 4,750
Multi User License: US$ 5,680
Corporate User License: US$ 7,750
The Liver Cancer Therapeutics Market is predicted to reach US$ by 2030 from US$ 1.8 billion in 2021, and to grow at a CAGR of 19.5% between the forecast period 2022 to 2030.

The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2021. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.

Major segmentation covered in this report is as follows:

By Therapy Type (Chemotherapy, Immunotherapy, and Targeted Therapy), by Distribution Channel (Retail Pharmacy, Online Pharmacy, and Hospital Pharmacy

By Region

North America, Europe, Asia Pacific, and the Rest of the World

Major market players covered in this study are

Pfizer Inc., Bristol-Myers & Squibb Company, Exelixis Inc., Merck Sharp & Dohme Corp., Eli Lilly & Company, F. Hoffman-La Roche Ltd., Eisai Co., Ltd., Celgene Corporation, Amgen Inc., and Onyx Pharmaceuticals, Inc. among others

1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2030
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Liver Cancer Therapeutics - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Liver Cancer Therapeutics - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Liver Cancer Therapeutics - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Liver Cancer Therapeutics - ANALYSIS & FORECAST, BY REGION
North America Liver Cancer Therapeutics
1. North America Liver Cancer Therapeutics , by Country
1. US
2. Canada
1. North America Liver Cancer Therapeutics , by Product
2. North America Liver Cancer Therapeutics , by Type
3. North America Liver Cancer Therapeutics , by Gender
4. North America Liver Cancer Therapeutics , by Sales Channel
3. Europe Liver Cancer Therapeutics
1. Europe Liver Cancer Therapeutics , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Liver Cancer Therapeutics , by Product
3. Europe Liver Cancer Therapeutics , by Type
4. Europe Liver Cancer Therapeutics , by Gender
5. Europe Liver Cancer Therapeutics , by Sales Channel
4. Asia Pacific Liver Cancer Therapeutics
1. Asia Pacific Liver Cancer Therapeutics , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Liver Cancer Therapeutics , by product
3. Asia Pacific Liver Cancer Therapeutics , by Type
4. Asia Pacific Liver Cancer Therapeutics , by Gender
5. Asia Pacific Liver Cancer Therapeutics , by Sales Channel
5. Rest of the World Liver Cancer Therapeutics
1. Rest of the World Liver Cancer Therapeutics , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Liver Cancer Therapeutics , by Product
3. Rest of the World Liver Cancer Therapeutics , by Type
4. Rest of the World Liver Cancer Therapeutics , by Gender
5. Rest of the World Liver Cancer Therapeutics , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 86

Synex Korea Healthcare Business Issue Report - DTx (Digital Therapeutics) 2023...

As defined by the FDA, Digital Therapeutics (DTx) is a "Software as a Medical Device (SaMD) that provides evidence-based therapeutic interventions to non-patients for the purpose of preventing, managing, or treating a medical disorder or disease based on biometric information collected from general-...

Cancer Immunosuppressant Treatment Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Cancer Immunosuppressant Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ...

Global Advanced Cancer Care Coordination Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Advanced Cancer Care Coordination Market: The report discusses everything a marketer requires before investing in the global Advanced Cancer Care Coordination Market during the forecast period...

Global Online Cancer Patient Registry Software Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Online Cancer Patient Registry Software Market: The report discusses everything a marketer requires before investing in the global Online Cancer Patient Registry Software Market during the for...

Global Cancer Pain Management Software Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Cancer Pain Management Software Market: The report discusses everything a marketer requires before investing in the global Cancer Pain Management Software Market during the forecast period 202...

Global Holistic Mindfulness Cancer Care Management Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Holistic Mindfulness Cancer Care Management Market: The report discusses everything a marketer requires before investing in the global Holistic Mindfulness Cancer Care Management Market during...

Global Cancer Registry Management Solutions Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Cancer Registry Management Solutions Market: The report discusses everything a marketer requires before investing in the global Cancer Registry Management Solutions Market during the forecast ...

Global Cancer Registry Quality Control Software Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Cancer Registry Quality Control Software Market: The report discusses everything a marketer requires before investing in the global Cancer Registry Quality Control Software Market during the f...

Global Early Cancer Screening Technologies Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Early Cancer Screening Technologies Market: The report discusses everything a marketer requires before investing in the global Early Cancer Screening Technologies Market during the forecast pe...

Global Advanced Therapeutics Pharmaceutical Outsourcing Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Advanced Therapeutics Pharmaceutical Outsourcing Market: The report discusses everything a marketer requires before investing in the global Advanced Therapeutics Pharmaceutical Outsourcing Mar...